scholarly journals I. M. Lvov. Narrowing of the external opening of the cervix and its improvement in a simplified way Borissowicz'a. (Weekly, 1894, No. 29, p. 485)

2020 ◽  
Vol 8 (10) ◽  
pp. 934
Author(s):  
N. Kakushkin
Keyword(s):  
Common Cause ◽  
External Opening ◽  
Inflammatory Changes

Making a brief outline of the pathology of narrowing of the cervical drip, the author points out the narrowing of the external opening, as a common cause (96%) of infertility in women and as a cause, together with inflammatory changes in the neck, painful months. When reducing the contraction, the author often resorts to cutting the neck (Sims) and praises this method.

scholarly journals Chronic gastritis and Helicobacter pylori in digestive form of Chagas' disease

1993 ◽  
Vol 35 (2) ◽  
pp. 117-121 ◽  
Author(s):  
A. J. A. Barbosa ◽  
D. M. M. Queiroz ◽  
A. M. M. F. Nogueira ◽  
M. J. A. Roquette Reis ◽  
E. N. Mendes ◽  
...  
Keyword(s):  
Helicobacter Pylori ◽  
Gastric Mucosa ◽  
Atrophic Gastritis ◽  
Chagas Disease ◽  
Chronic Gastritis ◽  
Antral Mucosa ◽  
Common Cause ◽  
Superficial Gastritis ◽  
H Pylori ◽  
Inflammatory Changes

Patients with the digestive form of Chagas'disease frequently present chronic gastritis. As the microorganism Helicobacter pylori is now accepted as the most common cause of human chronic gastritis, the present work was undertaken to verify a possible relationship between the presence of this bacterium and inflammatory changes of antral mucosa in chagasic patients. Seventeen chagasics, with megaesophagus and or megacolon were studied. Fragments from two different regions of antral mucosa were obtained by endoscopy, fixed in 4% neutral formaldehyde and embedded in paraffin. The sections were stained by haematoxylin and eosin for histology analysis, and by carbolfuchsin for H. pylori identification. H. pylori was found in 16 (94.1%) chagasic patients, all of them presenting chronic gastritis. Superficial gastritis was seen in 9 (52.9%) while atrophic gastritis was present in 8 (47.1%) patients. H. pylori was present on gastric mucosa of 8 (100%) patients with atrophic gastritis and of 8 (88.8%) patients with superficial gastritis. We concluded that the microorganism H. pylori should be considered a possible factor connected with the etiopathogenesis of chronic superficial and atrophic gastritis frequently observed in patients with the digestive form of Chagas' disease.

scholarly journals Autoimmune Ascites Responding to Mycophenolate Mofetil: A Case Report

2018 ◽  
Vol 12 (2) ◽  
pp. 207-216
Author(s):  
Douglas A. Simonetto ◽  
Hala Fatima ◽  
Folkert Zijlstra ◽  
Michael K. Zijlstra
Keyword(s):  
Heart Failure ◽  
Mycophenolate Mofetil ◽  
The United States ◽  
Pancreatic Disease ◽  
Interesting Case ◽  
Extensive Literature ◽  
Common Cause ◽  
United States Population ◽  
Abnormal Accumulation ◽  
Inflammatory Changes

Ascites is an abnormal accumulation of fluid within the peritoneal cavity. The most common cause of ascites in the United States population is portal hypertension secondary to cirrhosis, accounting for about 80% of the cases. Other etiologies include malignancy, heart failure, tuberculosis, and pancreatic disease. After an extensive literature review, it is to our best knowledge that there have been no cases reported on autoimmune ascites. We present an interesting case of ascites in a 67-year-old Caucasian male with symptoms of recurrent abdominal distention and significant weight gain, refractory to standard therapies. An extensive 3-year long workup was only significant for serum-ascites albumin gradient > 1.1 g/dL, ascitic fluid protein of 3.0 g/dL, and peritoneal biopsies showing minor inflammatory changes. Both common and rare causes of ascites were ruled out. Empiric treatment with mycophenolate mofetil (CellCept) resulted in resolution of symptoms with no need for a repeat paracentesis for > 2 years, suggesting the diagnosis of autoimmune ascites.

The Principle of the Common Cause

2009 ◽  
Author(s):  
Gabor Hofer-Szabo ◽  
Miklos Redei ◽  
Laszlo E. Szabo
Keyword(s):  
Common Cause ◽  
The Common

Vergleichende Qualitätsmessungen Teil 2: Regelkarten

Pflege ◽  
2013 ◽  
Vol 26 (2) ◽  
pp. 119-127 ◽  
Author(s):  
Jan Kottner ◽  
Armin Hauss
Keyword(s):  
Control Charts ◽  
Common Cause

Vergleichende Qualitätsmessungen und Beurteilungen spielen in der Pflege eine zunehmend wichtige Rolle. Qualitätskennzahlen sind von systematischen und zufälligen Fehlern beeinflusst. Eine Möglichkeit, mit zufälliger Variation in Kennzahlenvergleichen adäquat umzugehen, bietet die Theorie der Statistischen Prozesskontrolle (SPC). Im vorliegenden Beitrag werden Regelkarten (control charts) als Werkzeuge der SPC vorgestellt. Es handelt sich dabei um grafische Darstellungen von Qualitätskennzahlen im zeitlichen Verlauf. Attributive Merkmale können mithilfe von p-, u- und c-Regelkarten dargestellt werden. Es gibt eine Reihe von Regeln, mit denen spezielle Variationen (special cause variation) innerhalb des betrachteten Prozesses identifiziert werden können. Finden sich im Diagramm keine Hinweise auf nichtzufällige Variationen, geht man davon aus, dass sich der Prozess innerhalb «statistischer Kontrolle» befindet (common cause variation). Eine Abweichung eines Datenpunktes um mehr als drei Standardabweichungen vom Mittelwert aller vorliegenden Datenpunkte gilt als stärkstes Signal nicht zufallsbedingter Variation. Im Qualitätsmanagementkontext sind Regelkarten für die dynamische Messung von Prozessen und Ergebnissen und deren Beurteilungen traditionellen Mittelwerts- und Streuungsvergleichen überlegen.

Vergleichende Qualitätsmessungen Teil 3: Funnel Plots

Pflege ◽  
2014 ◽  
Vol 27 (1) ◽  
pp. 41-49 ◽  
Author(s):  
Jan Kottner ◽  
Nils Lahmann
Keyword(s):  
Common Cause ◽  
Sind Eine ◽  
Funnel Plots

Kennzahlenbasierte Qualitätsvergleiche von Einrichtungen sind verbreitet. Neben der Standardisierung und Risikoadjustierung muss die zufallsbedingte Variabilität in den Daten adäquat berücksichtigt werden. Rankings ohne Berücksichtigung der Präzision führen zu Fehlinterpretationen und fördern Datenmanipulationen. Konfidenzintervalle um die Kennzahlen der Einzeleinrichtungen sind eine Möglichkeit, die Präzision zu berücksichtigen. Funnel Plots als Spezialform von Regelkarten basieren auf der Theorie der Statistischen Prozesskontrolle (SPC). Darin werden die Kennzahlen in Beziehung zur Gruppengröße gesetzt. Warn- und Kontrollgrenzen, die sich 2 bzw. 3 Standardabweichungen vom Mittelwert aller Kennzahlen befinden, laufen mit steigender Fallzahl aufeinander zu und bilden einen Trichter. Kennzahlen innerhalb der Kontrollgrenzen weisen eine natürlicherweise zu erwartende Variabilität (common cause variation), Kennzahlen außerhalb der Kontrollgrenzen spezielle Variabilität (special cause variation) auf. Der Rankinggedanke ist aufgehoben. Funnel Plots bieten datenbasierte Kriterien, die Leistung von Einrichtungen im Qualitätsmanagement-Kontext zu bewerten.

Current perspectives in antithrombotic therapy

2001 ◽  
Vol 21 (03) ◽  
pp. 82-96 ◽  
Author(s):  
D. Hoppensteadt ◽  
O. Iqbal ◽  
R. L. Bick ◽  
J. Fareed
Keyword(s):  
Blood Coagulation ◽  
Antithrombotic Therapy ◽  
Thrombotic Event ◽  
The United States ◽  
Vascular Thrombosis ◽  
Common Cause ◽  
Coagulation Protein ◽  
Coronary Events ◽  
Platelet Defects

SummaryThrombotic disorders are the most common cause of death in the United States. About two million individuals die each year from an arterial or venous thrombosis or related disorders. About 80% to 90% of all cases of thrombosis can now be defined with respect to cause. Of these, over 50% occur in patients who harbor a congenital or acquired blood coagulation protein or platelet defect which caused the thrombotic event. It is obviously of major importance to define those individuals harboring such a defect as this allows: 1) appropriate antithrombotic therapy to decrease risks of recurrence; 2) determination of the length of time the patient must remain on therapy for secondary prevention; and 3) allow for testing of family members of those harboring a blood coagulation protein or platelet defect which is hereditary (about 50% of all coagulation and platelet defects mentioned above). Aside from mortality, significant additional morbidity occurs from both arterial or venous thrombotic events, including, but not limited to paralysis (non-fatal thrombotic stroke), cardiac disability (repeated coronary events), loss of vision (retinal vascular thrombosis), fetal waste syndrome (placental vascular thrombosis), stasis ulcers and other manifestations of post-phlebitic syndrome, etc.

Male Osteoporosis

2013 ◽  
Vol 22 (04) ◽  
pp. 260-266 ◽  
Author(s):  
S. P. Tuck ◽  
R. M. Francis ◽  
B. C. Hanusch
Keyword(s):  
Prostate Cancer ◽  
Older Men ◽  
Good Evidence ◽  
Male Osteoporosis ◽  
Fracture Rate ◽  
Common Cause ◽  
Increased Risk ◽  
Osteoporosis In Men ◽  
Considerable Morbidity ◽  
Secondary Causes

SummaryMale osteoporosis is common and results in considerable morbidity and mortality. There are distinct differences in the normal aging of bone between the genders, which result in a lower fracture rate in men. Men who suffer from osteoporosis are much more likely than women to have secondary causes. The identification and treatment of these secondary causes, wherever possible, will result in substantial improvements in BMD. There is now evidence for use of many of the existing agents to treat osteoporosis in men. In younger hypogonadal men testosterone replacement is worth considering, but in older men especially the over sixties this is less effective and there is an increased risk of adverse cardiovascular and prostatic outcomes. Prostate cancer is an increasingly common cause, which is partially the result of the success of ADT. There is now good evidence for the use of bisphosphonates and denosumab in this group of patients. HIV, whilst not being specific to men, is an increasingly recognised cause of male osteoporosis. The reasons for this are multifactorial and some may well be attributable to the anti-retroviral therapy itself. There is emerging evidence of an increased fracture risk in HIV infected individuals. The bone loss can be prevented by the use of bisphosphonates.

Sign in / Sign up

Export Citation Format

Share Document